Pharmacopsychiatry 2018; 51(01/02): 9-62
DOI: 10.1055/s-0043-116492
DOI: 10.1055/s-0043-116492
Review
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Authors
-
C. Hiemke
1 Department of Psychiatry and Psychotherapy, University Medical Center of Mainz, Mainz, Germany2 Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of Mainz, Mainz, Germany -
N. Bergemann
3 Kitzberg Hospitals, Center for Psychosomatic Medicine and Psychotherapy, Bad Mergentheim, Germany -
H. W. Clement
4 Department of Child and Adolescent Psychiatry, University of Freiburg, Freiburg, Germany -
A. Conca
5 Servizio Psichiatrico del Comprensorio Sanitario di Bolzano, Bolzano, Italy -
J. Deckert
6 Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Würzburg, Germany -
K. Domschke
7 Department of Psychiatry and Psychotherapy, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany -
G. Eckermann
8 Psychiatric Hospital, Kaufbeuren, Germany -
K. Egberts
9 Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Germany -
M. Gerlach
9 Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Germany -
C. Greiner
10 Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany -
G. Gründer
11 Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University, Aachen, and JARA – Translational Brain Medicine, Aachen, Germany -
E. Haen
12 Clinical Pharmacology, Department of Psychiatry and Psychotherapy and Department of Pharmacology and Toxicology, University of Regensburg, Regensburg, Germany -
U. Havemann-Reinecke
13 Department of Psychiatry and Psychosomatics, University of Göttingen, Göttingen, Germany -
G. Hefner
14 Psychiatric Hospital, Vitos Klinik, Eichberg, Eltville, Germany -
R. Helmer
15 Center of Epilepsy, Bielefeld, Germany -
G. Janssen
16 Medical Laboratory Stein, Limbach Group, Mönchengladbach, Germany -
E. Jaquenoud
17 Psychiatric Hospital, Königsfelden, Brugg, Aargau, Switzerland -
G. Laux
18 Institute of Psychological Medicine, Haag in Oberbayern, Germany -
T. Messer
19 Danuviuskliniken, Psychiatric Hospital, Pfaffenhofen, Germany -
R. Mössner
20 Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany -
M. J. Müller
21 Psychiatric Hospitals Oberberggruppe, Berlin, Germany -
M. Paulzen
11 Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University, Aachen, and JARA – Translational Brain Medicine, Aachen, Germany -
B. Pfuhlmann
22 Psychiatric Hospital Weisser Hirsch, Dresden, Germany -
P. Riederer
6 Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Würzburg, Germany -
A. Saria
23 Experimental Psychiatry Unit, Department of Psychiatry 1, Medical University of Innsbruck, Innsbruck, Austria -
B. Schoppek
24 kbo-Isar-Amper Klinikum München-Ost, Psychiatric Hospital, Munich-Haar, Germany -
G. Schoretsanitis
25 Department of Psychiatry, University of Bern, Bern, Switzerland -
M. Schwarz
26 Department of Laboratory Medicine, Ludwig Maximilian University, Munich, Germany -
M. Silva Gracia
12 Clinical Pharmacology, Department of Psychiatry and Psychotherapy and Department of Pharmacology and Toxicology, University of Regensburg, Regensburg, Germany -
B. Stegmann
12 Clinical Pharmacology, Department of Psychiatry and Psychotherapy and Department of Pharmacology and Toxicology, University of Regensburg, Regensburg, Germany -
W. Steimer
27 Institute of Clinical Chemistry and Pathobiochemistry, Technical University Munich, Munich, Germany -
J. C. Stingl
10 Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany -
M. Uhr
28 Max Planck Institute of Psychiatry, Munich, Germany -
S. Ulrich
29 Aristo Pharma GmbH, Berlin, Germany -
S. Unterecker
6 Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Würzburg, Germany -
R. Waschgler
30 Psychiatric Hospital, Feldkirch, Austria -
G. Zernig
23 Experimental Psychiatry Unit, Department of Psychiatry 1, Medical University of Innsbruck, Innsbruck, Austria31 Private Practice for Psychotherapy and Court-Certified Witness, Hall in Tirol, Austria -
G. Zurek
32 Medical Laboratory Bremen, Bremen, Germany -
P. Baumann
33 Department of Psychiatry, University of Lausanne, Prilly-Lausanne, Switzerland
